
Abdullah Boğa, MD
Abdullah Boğa, MD is a general surgery specialist at Acibadem Atakent Hospital. He has more than 12 years of experience in medicine and focuses on cholecystitis, umbilical hernia, incisional hernia and hemorrhoids. His work…
- Experience12+ years
- HospitalAtakent Hospital
- LanguagesTurkish, English
- FocusDigestive system diseases and surgery,…
About
Abdullah Boğa, MD is a General Surgeon at Acıbadem Atakent Hospital, with clinical interests in oncologic, colorectal, and digestive system surgery. His practice also includes the assessment and surgical treatment of gallbladder inflammation, groin and umbilical hernias, hemorrhoids, anorectal conditions, rectal prolapse, and pelvic pain or functional disorders.
Dr. Boğa graduated from Fırat University Faculty of Medicine in 2014 and completed his General Surgery training at Uludağ University Faculty of Medicine in 2021. He joined Acıbadem Healthcare Services in 2025.
International patients can expect a focused surgical consultation to discuss symptoms, diagnostic findings, and appropriate treatment options. Dr. Boğa provides care within the General Surgery, Digestive System Diseases and Surgery, and Hemorrhoid and Anorectal Disease Treatment units at Acıbadem Atakent Hospital.
Expertise
Conditions treated
- Cholecystitis
- Umbilical hernia
- Incisional hernia
- Hemorrhoids
- Anorectal disorders
- Rectal prolapse
- Pelvic pain and functional disorders
- Colorectal cancer
Procedures and treatments
- Oncologic surgery
- Colorectal surgery
- Digestive system surgery
- Cholecystitis treatment
- Hemorrhoids treatment
Education and career
Timeline
- 2025Acıbadem Healthcare ServicesCareer
- 2021Uludağ University Faculty of Medicine General SurgeryEducation
- 2014Fırat University Faculty of MedicineEducation
Tumour boards
Cancer types where Abdullah Boğa, MD is part of the specialist team
Send your reports and get a plan from a tumour board, not a single doctor
Pathology, imaging and previous treatment history are enough to start. Written recommendation within 48 hours, including trial eligibility.